ACP5 and cancer: Indeed, recent reports have implicated CTSK, ACP5 and SPP1/osteopontin in facilitating EMT and promoting metastasis in a number of cancers – particularly those with a high concentration of CD68-positive M2-like TAMs, which play a key role in invasion, metastatic spread and drug resistance37,38 e.g. in lung adenocarcinoma60.